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Abstract 
 Carpal tunnel syndrome (CTS) has shown increasing incidence rates over the last few 
decades. This upward trend will likely continue, correlating with increases in contributing 
factors, including obesity, diabetes, increased age, and occupational strain. Carpal tunnel 
syndrome is generally diagnosed clinically but confirmed with nerve conduction studies (NCS). 
The use of NCS as the gold standard has been argued in the literature, largely based on false 
negative rates up to 34%. Additionally, the invasive and costly nature of NCS has prompted the 
exploration of alternative methods. Sonography has shown great promise, reporting comparable 
predictive values in current literature.  Although sonography provides a cost-effective, well 
tolerated, non-invasive evaluation, clearly identified methods for diagnosing and categorizing the 
severity of CTS have not been established. The purpose of this pilot study was to determine if a 
blended approach using sonographic and clinical indicators could improve the predictive value 
and provide clinicians with a feasible alternative for diagnosing and categorizing the severity of 
CTS. A retrospective case-control study was conducted to identify the most sensitive variables 
and establish a severity classification method based on sonographic and clinical indicators. 
Symptomatic subjects and asymptomatic controls were compared, as were variables amongst 
NCS severity categories. Sonographic and clinical indicators associated with CTS included 
increased cross-sectional area (CSA), abnormal longitudinal appearance and restricted excursion 
of the median nerve, presence of classic and nocturnal symptoms, and positive provocative 
testing. Ultrasound severity categorization using a combination of these indicators matched 63% 
of NCS results, and 84% of asymptomatic controls were identified as normal using the scoring 
system. This pilot data is a useful step in isolating salient variables that could be further explored 
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in replicated studies with increased recruitment.  Confirmatory studies may provide clinicians 
with a holistic approach for the initial diagnosis and categorization of CTS.  
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Chapter 1: Introduction 
Background 
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy and the most 
common work-related musculoskeletal disorder. Although CTS is a known work-related injury, 
idiopathic and secondary CTS are also frequent diagnoses. Regardless of the etiology, the 
ensuing pathophysiology of the median nerve follows a similar path, resulting in CTS. Diagnoses 
may rely on clinical evaluations, electrodiagnostic studies (EDX), or sonographic examinations 
(US). The treatment of CTS varies according to severity, ranging from conservative treatments to 
surgical interventions.  
Carpal tunnel syndrome spans the globe, with general population incidence rates of 3.76 
per 1000 person-years in the United States to 4.96 per 1000 person-years in Korea, with 
incidence rates showing an increase over time.
1,2
 Increased incidence rates have been observed in 
employed CTS patients as compared to unemployed CTS patients, and particular occupations are 
considered at risk for developing work-related musculoskeletal injuries.
3
 Sonography is an 
example of an at-risk occupation due to the frequency, duration, and nature of the examinations. 
Studies have indicated approximately 65% of sonographers have experienced CTS symptoms 
during their career and over 90% have reported working in pain.
4-8
 Although occupational factors 
such  as repetitive strain, vibration, and malpositioning increase the risk of CTS, over 50% of 
CTS cases are idiopathic.
9
 Secondary CTS may result from conditions and diseases including 
pregnancy, obesity, diabetes, thyroid disorders, rheumatoid arthritis, amyloidosis, trigger digit, 
and cervical radiculopathy. Space occupying lesions or masses located within the carpal tunnel 
may also cause secondary CTS.
10-12
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Repeated or endured compression and stress on the median nerve creates a cascade of 
pathological responses, resulting in carpal tunnel syndrome. Elevated pressure and stress cause 
impaired nerve perfusion, triggering ischemia and damage to the nerve-blood barrier within the 
endoneurial capillaries. Leakage from the microvessels into the endoneurium leads to increased 
pressure and edema. Edema initiates the inflammation process as fibroblasts infiltrate the region. 
The ensuing fibrosis results in scar tissue formation, axonal injury, and localized demyelination. 
Diffuse demyelination and Wallerian degeneration occur with prolonged stress.
10-14
 Symptoms 
progress as the severity of the individual’s CTS increases. Early symptoms include intermittent 
numbness, tingling, burning, or pain in the lateral palm, thumb, index and middle fingers. 
Nocturnal symptoms may also occur, causing affected individuals to awaken from pain and 
numbness. Symptoms progress to grip and digit awkwardness, constant numbness, and decreased 
pain due to sensory loss as CTS severity increases. At the advanced stage of CTS, the patient 
experiences muscle atrophy and increased weakness.
1,4,10,11
    
 Diagnosis of CTS often relies on a clinical diagnosis, confirmed by EDX testing. 
Sonographic examinations have also proved useful for the evaluation of CTS. Clinical diagnosis 
should include symptom specifics, such as location, characteristics, and provocative and 
mitigating factors, and may include the use of functional status surveys (FSS) and symptom 
severity surveys (SSS), such as the Boston Carpal Tunnel Questionnaire. Clinical diagnoses also 
utilize physical testing including Phalen’s test, Reverse Phalen’s test, Tinel sign, carpal tunnel 
compression test (with and without wrist flexion), and hand elevation test. Electrodiagnostic tests 
include electromyography (EMG) and nerve conduction studies (NCS). Of the two, NCS is the 
more commonly used EDX testing.
10
 Although EDX, more specifically NCS, has historically 
been considered the gold standard for confirming CTS diagnosis, its use as the gold standard has 
3 
 
been debated within the research literature.
1,15-17
 Radiologic imaging, including sonography, has 
also been incorporated as a diagnostic tool. Sonographic evaluations of CTS patients typically 
evaluate the cross-sectional areas (CSA) of the median nerve at the proximal carpal tunnel. 
Magnetic resonance imaging (MRI) and computed tomography (CT) has also been employed in 
the diagnosis of CTS.  
Treatment of CTS also varies according to the severity of the pathology. Conservative 
treatment includes splinting, oral medications, and injections such as corticosteroids. In more 
advanced CTS, surgery may be necessary. Carpal tunnel surgery involves the division of the 
transverse carpal tunnel ligament to alleviate compression of the median nerve, and may be 
performed either openly or endoscopically. Open carpal tunnel release is the most common 
surgical method, and has shown high success rates.
10
 Although surgery usually has a high 
success rate, some CTS patients may have persistent symptoms, requiring further evaluation.
9,10
 
 
Significance of the Problem 
 Current trends in CTS risk factors will likely result in an increased prevalence of CTS. 
Diabetes, obesity, an increasing life span, and occupational risks are several of the contributing 
factors expected to increase the incidence rate.
1,3,10
 Research has indicated a prevalence rate of 
diabetes and obesity twice as high in CTS patients than that found in the general population.
3
 As 
these trends increase so too will the need for a reliable, non-invasive method of assessing and 
diagnosing CTS. Clinical diagnosis, including symptoms and physical tests, has been shown to 
have high predictive values, and has been utilized as the gold standard in several studies rather 
than NCS.
15,16,18
 More commonly, a clinical diagnosis of CTS is followed by confirmatory EDX 
4 
 
studies. Electrodiagnostic studies are invasive, uncomfortable, time consuming, and costly. 
Additionally, the results of EDX studies are questionable, including high rates of false-positives 
and a wide range of sensitivities reported within the research.
2,9,15-17,19
  
  Sonography is widely available throughout the world and examinations are cost-
efficient, portable, and well tolerated by patients. The non-invasive nature and lack of radiation 
makes sonography an ideal modality for repeat examinations. The sonographic evaluation of 
CTS is commonly used but sensitivity rates have not consistently exceeded those of NCS. 
Evaluation of the CSA of the median nerve has been reported as beneficial for sonographically 
assessing CTS.
9,10,12,15,18-24
 It has been proposed that sonography may replace NCS as a first-line 
test to confirm clinically diagnosed CTS, potentially eliminating the need for NCS in over 50% 
of the patients.
15,18
 Evaluating multiple variables, both sonographic and clinical CTS indicators, 
may provide a more inclusive assessment of physiologic changes in the median nerve and the 
most accurate representation of the patient’s pathology.  
 
Research Objective 
  An increase in sensitivity, specificity, and predictive value rates is necessary before 
implementing the wide-spread use of sonography as a first-line diagnostic tool for CTS. The 
current trend in sonographic investigation of CTS focuses primarily on median nerve CSA 
however a multivariate approach may add value to the sonographic examination. Because of the 
complex cascade of pathological effects observed in the development and advancement of CTS, 
multiple factors should be assessed. Specifically, the median nerve should be evaluated for an 
increased CSA, abnormal longitudinal appearance, restricted excursion, and intraneural 
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vascularity. By assessing multiple variables in addition to the CSA, sonographic evaluation 
efficacy may match the gold standard of diagnosis provided by NCS in the detection and 
evaluation of clinically diagnosed CTS. 
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Chapter 2: Literature Review 
 As mentioned previously, clinical diagnosis relies on patient history, specifically 
symptom characteristics, and physical testing (Phalen’s, Reverse Phalen’s, Tinel, carpal tunnel 
compression, hand elevation). It is not uncommon for research studies to refer to clinical 
diagnosis as the gold standard in lieu of NCS. A general population study in Korea, including 
97% of the population, reported 80% of CTS patients did not undergo electrodiagnostic testing 
(EDX), with medical practitioners relying solely on clinical diagnosis.
2
 The presence of multiple 
primary symptoms of CTS has been found to have a high predictive value.
15-18
 Although some 
studies have indicated relatively low sensitivities and specificities for individual clinical tests,
25
 
an increase in their predictive value when combined with other clinical indications and testing 
has been reported, with sensitivity rates as high as 99%.
15-18
  
 Electrodiagnostic studies are often used to confirm clinically diagnosed CTS. Nerve 
conduction studies evaluate the function of the median nerve, measuring the sensory and motor 
latencies, amplitudes, and velocities of the median nerve. Because EDX requires needles to be 
inserted into the upper extremity, it is considered an invasive and uncomfortable procedure. 
Nerve conduction studies are also costly; with a reported cost twice that of a sonographic 
examination.
15
 While it is often referred to as the gold standard in research, its added value for 
clinically diagnosed CTS has been questioned.
15
 Nerve conduction studies have consistently 
reported higher sensitivity ratings than sonography, however false-positives and false-negatives, 
especially in asymptomatic patients or cases of mild CTS, plague the use of NCS.
15-17,24
 False-
positive rates ranging from 10-20% and false-negative rates of 16-34% in clinically diagnosed 
CTS patients have been reported. Similarly, it has been reported that less than 50% of 
asymptomatic patients had positive NCS findings.
16,24
 Sonography has been proposed as an 
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alternative to NCS as a confirmatory tool for CTS, with hopes of a well-tolerated examination, 
reduced medical expenses, and a diagnostic findings equal to or greater than those of NCS. 
 The majority of sonographic evaluations have relied on the CSA of the median nerve to 
evaluate the presences of CTS, with increasing areas correlating to an increase in severity.
20,24
 
Edema is one aspect of compressive neuropathies, resulting in the swelling of the median nerve 
at the carpal tunnel inlet. The flexor retinaculum flattens the median nerve as it travels through 
the carpal tunnel. As the median nerve exits the carpal tunnel distally it again takes on a swollen 
appearance. The cross-sectional imaging of the median nerve allows the area to be calculated 
using either direct trace methods or anteroposterior and mediolateral diameters. Cross-sectional 
area has been found to correlate well with both patient-oriented parameters, such as the Boston 
Carpal Tunnel Questionnaire, and with NCS findings.
24
 In a meta-analysis of 19 prospective 
studies (3131 wrists) comparing sonography to clinical and NCS diagnoses, Fowler et al.
15 
reported sonography had a sensitivity and specificity of 77.6% and 86.8%, respectively, when 
evaluating CSA. Sensitivities ranged from 57-98% and specificities ranged from 63-100%. The 
authors concluded the accuracy of sonographic evaluation may improve with higher CSA cut-off 
values employed.     
 The location for imaging CSA varies within the research as does location definitions.
16,22
 
Cross-sectional areas have been imaged proximal to the carpal tunnel, at the carpal tunnel inlet, 
and distal to the carpal tunnel, as well as in the forearm. Common verbiage describing imaging 
locations include carpal tunnel inlet, proximal carpal tunnel, distal carpal tunnel, carpal tunnel 
outlet, and at the wrist crease (also using locators such as distal, mid, and proximal). The location 
is often identified by the carpal bones, such as the level of the pisiform, but this too varies within 
research.
16 
The location may affect the significance of the findings. Rahmani et al.
19
 determined 
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there were significant differences between CTS patients and controls when the CSA was 
acquired at the wrist but when imaged at the forearm there were no differences between the 
groups. Akcar et al.
21 
found statistically significant differences between CTS and control groups 
when the CSA was acquired at “mid-level”, located at the level of the pisiform, but the CSA 
acquired proximal to the carpal tunnel inlet was not found to be a “clinically important 
predictor”. A systematic review conducted by Roll et al.25 postulated the pisiform would identify 
the level of the mid-carpal tunnel because of the distal arching of the proximal row of carpal 
bones. Roll suggested using the distal radial-ulnar joint, pisiform, and hamate as the carpal 
tunnel inlet, mid-carpal tunnel, and outlet, respectively.  The most accurate CSA measurements 
were at the level of the pisiform, followed by CSA measurements immediately proximal to the 
inlet. Measurements at the distal carpal tunnel had the lowest accuracy, with a sensitivity rate 
ranging from 18-65%.
25
 Area differences between the CSA values proximal to and within the 
carpal tunnel has shown diagnostic accuracy in confirming CTS. Akcar evaluated the CSA area 
difference between the level of the pisiform (CSAb) and proximal to the carpal tunnel (CSAa). 
Using a cut-off value of 3.65, CSA area difference (CSAb-CSAa) reported 83% sensitivity and 
82% specificity.
21
 
Although the level at which the measurements are acquired has been debated, an 
increased CSA is considered a consistent criterion.
9,10,12
 Padua et al. found a significantly strong 
positive relationship between increasing CSA values and the increasing severity of clinical 
impairment in CTS patients (r=0.80, p<0.0000001).
20 
El Miedany et al.
24
 also evaluated CSA 
values to propose a severity grading system based on a strong correlation between increasing 
CSA levels and EMG and clinical findings. The authors proposed a CSA of 10-13mm² as mild, 
13-15mm² as moderate, and greater than 15mm² as severe.
24
 Optimal cut-off points have varied, 
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ranging from 9mm² to 15mm² throughout the research.
6,9,12,15,16,18,21-24
 Cross-section area has 
proven to be valuable in the assessment of CTS, however varying cut-off points have affected the 
comparison of sensitivity ratings.  
Excursion is a measure of the distance traversed by the median nerve as it glides through 
the nerve bed during flexion and extension movements. As the nerve bed is elongated, stress and 
strain of the median nerve occur. Increased strain negatively impacts conduction and blood flow 
within the nerve, leading to nerve injury.
14,26
 In addition to nerve bed elongation during 
movement, physiologic changes occurring in CTS may invoke an increased strain on the median 
nerve.
 9,11,13,14,26
  Inflammation of the median nerve impedes movement through the carpal 
tunnel. Collagen deposition and fibrosis may cause thickening of the connective tissue, impairing 
nerve gliding. Fibrosis and scarring can also cause adhesion of the median nerve to surrounding 
tissue, reducing excursion by a tethering effect.   
Studies have indicated specific positions and movements evoke specific excursion 
reactions. Forearm supination results in a greater excursion than pronation,
27
 extension results in 
a greater excursion than flexion, 
27,28 
and distal excursion results from extension rather than 
flexion.
26,27,29-31
 Median nerve excursion measurements have varied in the research. Wright et al. 
observed a 9.2mm excursion upon wrist extension in cadavers.
26
 Lower excursion rates in 
healthy individuals were demonstrated by the Dilley et al. and Echigo et al. in vivo studies, 
ranging from 2.6-6.0mm and 1.8-3.0mm upon wrist extension, respectively.
27,30,32  
Two 
sonographic modes commonly used to evaluate longitudinal median nerve excursion are spectral 
Doppler and frame-by-frame cross-correlation analysis. Doppler imaging encompasses capturing 
the longitudinal excursion test movements and correlating Doppler waveforms. The extension 
phases of the test movements are traced, resulting in velocity time integrals (VTI) representing 
10 
 
the median nerve excursion. The VTI are calculated in pixels and then converted into millimeters 
using programs such as Excel.
28,33
 The accuracy of the Doppler technique is approximately 
±0.7mm, and the test-retest reliability had an intraclass correlation coefficient of 0.92.
28,33
 Cross-
correlational analysis entails imaging the excursion with a frame rate approximately 10 frames 
per second. A region of interest (ROI) is selected and fine structures are marked within the ROI. 
Pixel gray levels within the region are evaluated in adjacent frames, with pixel shifts 
corresponding to nerve excursion. To increase the accuracy, frame intervals are increased and 
analysis is carried out with 1-3 frames between the compared frames. In vivo measurements 
were found to be reliable measuring movement with less than a 10% error.
32
  
It has been hypothesized that excursion rates would be reduced in CTS patients as 
compared to controls. Hough
28
 reported a significantly lower excursion rate;
 
however Erel et al.
29
 
found no significant difference between CTS patients and controls. This difference in significant 
findings may be due to the varying methods utilized in the studies. Employing the Doppler 
technique, Hough measured excursion with the transducer placed longitudinally at the carpal 
tunnel, with the Doppler sample volume indicator at the location of the lunate-capitate 
intercarpal joint. From a starting position of either a fully extended or 90˚ flexed elbow, wrist 
extended 30˚, and fingers fully flexed, excursion was measured as the fingers extended to the 
maximal allowed amount. Erel measured excursion employing frame-by-frame cross-correlation 
with the transducer placed 5-15cm proximal from the distal wrist crease. From a starting position 
with the elbow fully extended and the wrist in neutral, the fingers were extended from a 90˚ 
flexion to neutral. With both the wrist and the elbow started in an extended position, Hough 
found a significant reduction of excursion in CTS patients (8.3mm) compared to controls 
(11.2mm). With the wrist in neutral and the elbow extended, Erel did not find a significant 
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reduction in median nerve excursion in CTS patients (2.2mm) compared to controls (2.6mm). It 
is unclear if the positioning differences or the measurement techniques could be responsible for 
the disagreement between the two studies.
28,29 
Blood is supplied to the median nerve by the radial and ulnar arteries and supply from a 
persistent medial artery is a normal variant. As the median nerve courses through the carpal 
tunnel, blood flow is also supplemented by the superficial palmar arch. Injury to the microvessels 
within the endoneurium results from endured compression and strain, causing ischemia and 
venous congestion. Edema and inflammation trigger an increased blood flow to the area, further 
increasing the pressure within and surrounding the carpal tunnel. As inflammation of the nerve 
ensues, longitudinal images of the median nerve demonstrate a “notched” appearance as the 
nerve passes under the flexor retinaculum. This abnormal appearance of the median nerve has 
been employed for the evaluation of CTS. Kele et al.
34
 observed 50% of patients had longitudinal 
compression signs and 39 patients had bulbous nerve swelling. Longitudinal compression had 
50% sensitivity and 100% specificity. Wang et al.
35
 introduced a semi-quantitative scale to 
evaluate longitudinal compression sign (LCS), using grades 0-3 to categorize the distortion. A 
significant difference between subjects and controls (p < 0.001) was reported, with sensitivity 
and specificity rates of 50.0% and 95.8%, respectively.  
Hypervascularity at the carpal tunnel inlet is a common presentation in CTS patients. 
Rahmani et al.
19
 evaluated hypervascularity using color Doppler in CTS patients with clinical 
presentations but normal EDT findings, reporting a significantly higher hypervascularity in CTS 
patients compared to controls [odds ratio (OR) 5.004]. Only intraneural hypervascularity was 
considered abnormal, differentiating hypervascularity from normal perineural and prominent 
median artery vascularity.  Mallouhi et al.
22
 reported similar findings with a 91% accuracy for 
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detecting CTS compared to NCS when evaluating hypervascularization with color Doppler 
sonography. Of the 5 sonographic criteria employed, hypervascularization had the highest 
sensitivity, positive predictive value, and negative predictive value (95%, 94%, and 75%, 
respectively).   
 Improvements in predictive values have been made by employing multivariate 
sonographic examinations. Rahmani et al.
19
 evaluated median nerve CSA, echogenicity, and 
vascularity in clinically-evidenced CTS patients with normal NCS findings. Using multivariate 
linear regression analysis, the probability of having clinically-evidenced CTS improved as more 
sonographic signs were identified. With identification of one sign the probability was 35%, with 
two it increased to 70%, and with three signs identified the probability increased to 90%. 
Mallouhi et al.
22
 also conducted multivariate examinations to evaluate sonographic predictors of 
CTS. Of 153 CTS wrists, the presence of both hypervascularity and increased CSA were found 
in 89% of the wrists compared to 9% having only one of the two signs. Similar improvements 
were shown by Rempel et al.
17
 upon evaluation of specificities of clinical findings. Specificity 
increased from 76% with the presence of positive physical examinations to 99% with the 
presence of positive physical examinations, classic or probable symptoms, and night symptoms. 
Altinok et al.
36
 also reported increased sensitivity, specificity, and overall accuracy by evaluating 
multiple variables. The authors determined the most sensitive variables for diagnosing CTS were 
swelling ratio (72.5%), CSA at the pisiform level greater than 9mm² (65%), and palmar 
displacement (62.5%). When two out of the three criteria were present, the sensitivity increased 
to 95% in identifying moderate CTS and had an overall accuracy of 83.3% for properly 
classifying normal, mild, and moderate CTS groups. Given that cross-sectional area, longitudinal 
appearance, excursion, and intraneural vascularity have not been combined as diagnostic 
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parameters to evaluate CTS, multivariate evaluations may prove valuable as a set of diagnostic 
criteria for detecting and staging the severity of CTS.  
 
Research Question 
 Since the use of multiple sonographic measures to diagnose and categorize the severity of 
CTS has rarely been addressed in the literature, a gap exists. This study was proposed to address 
this gap with the following research question: 
Will the sonographic evaluation of multiple carpal tunnel syndrome indicators, including 
increased cross-sectional area, abnormal longitudinal appearance, restricted excursion, and 
intraneural vascularity of the median nerve, aid in the detection and severity categorization of 
carpal tunnel syndrome? 
By investigating this research question, information may be attained that will expand the scope 
of sonographic evaluation of carpal tunnel syndrome.  
14 
 
Chapter 3: Methods and Analysis 
Materials and Methods 
Patients 
 A retrospective, age and gender matched case-control study was conducted from May 
2010 through October 2011. A convenience sample of 38 wrists included 13 symptomatic 
subjects (19 wrists) and 13 asymptomatic controls (19 wrists). (Figure 3.1) The subjects and 
controls were matched by examination age within 36 months, gender, and wrist, with the 
exception of one subject matched to the control’s contralateral wrist. Individuals were excluded 
if a history of uncontrolled diabetes, fractures affecting the carpal tunnel region, previous carpal 
tunnel release surgery, or current pregnancy was indicated in the medical history. Individuals 
with bifid median nerves or space occupying mass in the carpal tunnel were also excluded. 
Symptomatic subjects had sonographic evaluations performed immediately following NCS by a 
sonographer blinded to the NCS results. Physical examinations and severity surveys were also 
completed at the time of sonography. Evaluations were performed at The Ohio State University’s 
Cramblett Outpatient Clinic Nerve Conduction Clinic in Columbus, Ohio. The research study 
was granted approval by The Ohio State University’s Biomedical Institutional Review Board.  
Nerve Conduction Studies 
 Nerve conduction studies were considered the gold standard to determine the presence 
and severity of CTS. Both positive and negative findings were included in the study, and the 
sonographer was blinded to the NCS results. Carpal tunnel syndrome severity was categorized as 
normal, mild, moderate, or severe, using guidelines set by The Ohio State University Nerve 
Conduction Clinic based on standards established by the American Association of  
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Figure 3.1 Subject Flow Chart  
Assessed for CTS: 
33 wrists 
29 symptomatic wrists 
17 Subjects: 
12 Bilateral symptoms 
5 Unilateral symptoms 
24 symptomatic wrists 
19 symptomatic wrists: 
12 right wrists 
7 left wrists 
4 asymptomatic wrists 
Exclusion criteria: 
3 Bifid median nerves 
1 CT release surgery 
1 ulnar neuropathy 
5 unmatched wrists 
16 
 
Neuromuscular and Electrodiagnostic Medicine (AANEM). Subjects with sensory values of No 
Response (NR) were automatically categorized as severe. For comparative purposes, values were 
assigned to the NCS severity categories as follows: 1-normal, 2-mild, 3-moderate, 4-severe. 
Clinical Examination 
 Individuals were physically examined prior to the sonographic evaluation. Height and 
weight were attained and the BMI was calculated accordingly. As a precursor to nerve excursion 
evaluation, maximum extension of the wrist was documented. With the forearm resting medially 
on a table, test subjects were asked to extend the wrist as far as possible. A goniometer was used 
to measure the angle between the lateral forearm at the radial stylus process and the index finger 
to determine the maximum range of motion (ROM) angle. Provocative testing, including 
Phalen’s, Tinel, and Durkan testing, was performed. Testing was considered positive if the 
individual experienced pain, tingling, or numbness in the hand or wrist within one minute. All 
individuals completed questionnaires pertaining to symptom and functional status severity. From 
the completed questionnaire, the absence or presence of classic symptoms and nocturnal 
symptoms were documented. Classic symptoms were considered present if the individual had 
symptoms of numbness, tingling, and/or pain in the hand or wrist within two weeks prior to 
evaluation. Nocturnal symptoms were considered present if pain, numbness, and/or tingling 
woke the individual more than once in the two weeks prior to evaluation.     
Sonographic Evaluation 
 The median nerve was imaged in transverse and longitudinal planes using high-resolution 
real-time sonography. Individuals were positioned with the forearm supine, the elbow semi-
flexed, and the fingers and the wrist in a neutral position. Evaluations were performed using a  
17 
 
 
 
GE Logiq i hand-carried sonographic machine and an 8-12.0 MHz, 43mm linear array transducer 
(GE Healthcare Clinical Systems, Wauwatosa, Wisconsin). Imaging was performed using the 
musculoskeletal (MSK) preset, harmonics, and CrossXBeam technology. 
 The median nerve CSA evaluations were performed in a transverse plane at the carpal 
tunnel inlet (CSAa) and mid carpal tunnel (CSAb), using the distal radial-ulnar joint and 
pisiform as anatomical landmarks, respectively. (Figure 3.2) A direct trace method was used to 
record the CSA, with tracings performed within the epineurium. (Appendix III) Five CSA 
measurements were attained at both levels; the highest and lowest values were discarded with the 
remaining three values averaged to determine the mean CSA. Using the CSA means from both 
locations, the largest CSA (CSAmax) was also recorded. A cut-off value of 10mm² was 
considered abnormal. Additionally, the CSA area difference was calculated between CSAa and 
CSAb, with an absolute value difference greater than 3.65 considered abnormal.  
Figure 3.2 Carpal Tunnel Anatomy at the Level of the Pisiform (European Society of Musculoskeletal Radiology. Musculoskeletal 
Ultrasound Technical Guidelines, http://www.essr.org/html/img/pool/wrist.pdf) 
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 Longitudinal appearance, excursion, and intraneural vascularity were evaluated in a 
longitudinal plane over the carpal tunnel region. (Appendix III) The longitudinal appearance of 
the median nerve was evaluated for signs of enlargement and compression by the flexor 
retinaculum. Proximal and distal enlargement and compression were subjectively categorized as 
present or absent. Cine clips of excursion were obtained at the proximal carpal tunnel inlet using 
gray-scale sonography. Beginning in the aforementioned starting position, the individual was 
instructed to slowly extend the wrist from neutral to the maximal extension angle. This maximal 
amount was assumed to be the same degree of extension as measured with the goniometer prior 
to sonographic examination. Forward (distal) movement of the median nerve was evaluated 
using frame-by-frame analysis of the cine clip. Landmarks within the median nerve and carpal 
tunnel were used to subjectively categorize the excursion as normal or restricted. To evaluate 
intraneural vascularity within the median nerve, the nerve was imaged using both gray-scale and 
Doppler sonography. Color Doppler PRF ranged from 0.4-0.6 KHz, depending on the subject. 
Spectral Doppler was used to evaluate vascularity. Intraneural vascularity was categorized as 
present or excluded using the following exclusion criteria, developed by Evans et al.
37
:  1) Must 
demonstrate at least 3 cardiac cycles in the sample, 2) must have the spectral Doppler gate 
positioned within the median nerve, 3) must have more than pulsatility in the spectral tracing, 4) 
must have an optimized gray scale image, 5) must have a signal greater than noise ratio, and 6) 
must have a color pixel within the spectral Doppler gate.      
Sonographic Severity Categorization 
 A scoring matrix was developed incorporating multiple sonographic and clinical CTS 
indicators to categorize the CTS severity. Carpal tunnel syndrome severities were categorized as  
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normal, mild, moderate, and severe. Categories were assigned the same values as the NCS 
categories for comparative purposes (normal-1, mild-2, moderate-3, severe-4).  Subjects and 
controls were both scored and categorized. Categories were assigned according to the number of 
positive CTS indicators (normal=0-1, mild=2-4, moderate=5-7, severe=8-9). (Table 3.1, 3.2) 
 
Statistical Analysis 
 Mean values, ranges, and standard deviations (SD) were calculated for age, BMI, CSAa, 
CSAb, CSAmax, CSA area difference, and ROM. Data entry and statistical analysis was 
performed using Microsoft Excel 2010 and SPSS Version 19 for Windows (Chicago, IL). 
Binomial statistics were coded using 1 for normal (negative), 2 for abnormal (positive), and 0 for 
excluded or missing values. Student t tests (two-tailed, assuming unequal variances) were 
performed to compare independent variables between subject and control groups. Spearman 
correlations and Student t tests (two-tailed, assuming equal variances) were performed to 
determine the association and statistical significance between subject independent variables (age, 
CATEGORY SEVERITY 
POSITIVE 
MARKERS 
1 Normal 0-1 
2 Mild 2-4 
3 Moderate 5-7 
4 Severe 8-9 
Sonographic and Clinical Indicators 
CSAmax > 10mm² 
CSAmax > 13mm² 
CSAmax > 15mm² 
Longitudinal Compression 
Proximal Enlargement 
Restricted Excursion 
Positive Provocative Test 
Classic Symptoms Present 
Nocturnal Symptoms Present 
Table 3.1 CTS Indicators for US Severity 
Table 3.2 US Severity Categories 
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BMI, CSAa, CSAb, CSAmax, CSA area difference, ROM) and NCS severity. Chi-square 
analysis was used to calculate the agreement between sonographic (US) and NCS severity 
categories. P values > 0.05 were considered statistically significant. Strength of association was 
considered weak (< 0.3), moderate (0.3-0.7), or high (> 0.7).
38
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Chapter 4: Results 
Demographics 
 The subject cohort consisted of 13 individuals (9 female, 69.23%). Symptoms were 
bilateral in 6 subjects and unilateral in 7, for a total of 19 wrists. Subject age ranged from 23-62 
years (mean age, 43.85 ± 10.71 years) at the time of the examination. The control cohort 
consisted of 13 individuals (9 female, 69.23%) and 19 wrists. Control age ranged from 23-61 
years (mean age, 43.84 ± 10.02 years) at the time of the examination. Mean subject BMI (30.39 
± 9.55) and control BMI (27.72 ± 5.09) were not significantly different (p>0.05). (Table 4.1) 
Subjects versus Controls 
 Mean CSA measurements were significantly increased in subjects as compared to control 
CSA values (Table 4.1, Figure 4.1). The mean CSAa (13.00 ± 3.91mm
2
) and CSAb (12.98 ± 
3.24mm
2
) in subjects was statistically significant compared to CSAa (9.52 ± 3.25mm
2
) and 
CSAb (8.86 ± 2.89mm
2
) in controls (p<0.01 and p<0.0001, respectively). Additionally,  
 
 
 
 
 
 
 
 
Table 4.1 Subject and Control Variable Means ± SD and Significance, reported as mean ± SD 
Variable Subject Control p= 
Age, years 43.85 ± 10.71 43.46 ± 10.95 0.93 
% Female 69.23% 69.23%  
BMI 30.39 ± 9.55 27.72 ± 5.09 0.38 
CSAa, mm² 13.00 ± 3.91 9.52 ± 3.25 < 0.01 
CSAb, mm² 12.98 ± 3.24 8.86 ± 2.89 < 0.001 
CSAmax, mm² 14.76 ± 3.86 10.36 ± 3.35 <0.001 
CSA Area Difference, mm² 3.53 ± 2.78 2.35 ± 1.95 0.14 
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CSAmax was significantly increased in subjects (14.76 ± 3.86) compared to controls (10.36 ± 
3.35mm²) (p<0.001). Using a cut-off value of 10mm
2
, 84.21% of subjects had a CSAmax over 
the cut-off value compared to 52.63% of controls. The difference between subjects and controls 
increased as the CSAmax increased to more than 15mm
2
, 47.37% of subjects compared to 5.26% 
of controls.  The mean CSA area difference was not found to be significantly different between 
the two groups (p>0.05).  
 While none of the controls presented with abnormal longitudinal median nerve 
appearance, 52.63% of subjects had at least one abnormal presentation. Of the three evaluated, 
compression was the most frequent (52.63%), followed by proximal enlargement (42.11%) and 
distal enlargement (10.53%). Controls had a greater percentage of intraneural vascularity 
compared to subjects, 63.16% and 52.63%, respectively. Restricted excursion was observed in 
 
Figure 4.1  Variable Frequencies in Subject and Control Groups 
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26.32% of subjects and was only observed in subjects with a CSAmax greater than 15mm
2
.
 
Range of motion (ROM) and excursion were not evaluated in the control cohort. Clinical 
evaluation included provocative testing and symptom presentations. Provocative testing was 
normal in all controls and none experienced classic or nocturnal symptoms. By comparison, 
42.11% of subjects had at least one positive provocative test, 84.21% experienced classic 
symptoms, and 57.89% reported nocturnal symptoms. (Appendix VII) 
Subjects versus NCS Severity 
 At the wrist level analysis, mean subject age and BMI were slightly higher than the 
individual level due to the increased sample (13 individuals compared to 19 symptomatic wrists), 
with a mean subject age of 43.89 ± 9.68 and BMI of 32.03 ± 10.08. Increases in subject BMI, 
CSAa, CSAb, and CSAmax had statistically significant moderate associations with increasing 
severity based on NCS (Table 4.2). Age, CSA area difference, and ROM had weak associations 
with increasing severity, and of the variables CSA area difference was not significant (p>0.05). 
 
 
 
 
 
 
 
 
VARIABLE MEAN (±SD) p= r= 
Age, years 43.89 (9.68) <0.01 0.24 
BMI 32.03 (10.08) <0.01 0.60 
CSAa, mm
2
 13.00 (3.91) <0.01 0.36 
CSAb, mm
2 
12.98 (3.24) <0.01 0.53 
CSAmax, mm
2
 14.76 (3.86) <0.01 0.49 
CSA Area Difference (CSAb-CSAa), mm
2
 3.53 (2.78) 0.25 0.24 
ROM, degrees 48.53 (14.94) <0.01 -0.20 
Table 4.2 Mean, SD, and Significance of Subject Variables (wrist level) Compared to NCS Severity 
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Table 4.3 Subject Variable Percentages by NCS Severity 
 
 Based on NCS, severity categorization resulted in 2 normal, 7 mild, 4 moderate, and 6 
severe CTS subjects. (Figure 4.2) Subject BMI increased with severity, increasing from 21.55 in 
normal subjects to 39.62 in severe subjects, as did CSAb, increasing from 9.92 ± 0.09mm² in 
normal subjects to 14.94 ± 2.85mm² in severe subjects. (Table 4.4) Severe CTS subjects had the 
highest percentage of sonographic variables, and the majority of severe subjects had a CSAmax 
greater than 15mm
2
 (83.33%). Restricted excursion was only observed in moderate and severe 
subjects. (Table 4.3) 
  
  Figure 4.2 Subject Severity Based on NCS            Figure 4.3 Subject Severity Based on US Scoring     
2 
7 
4 
6 
NCS Subject Severity 
Normal
Mild
Moderate
Severe
1 
7 
6 
5 
US Subject Severity 
Normal
Mild
Moderate
Severe
Variable Normal (n=2) Mild (n=7) Moderate (n=4) Severe (n=6) 
CSAmax > 10mm
2
 50.00% 85.71% 75.00% 100.0% 
CSAmax > 13mm
2
 50.00 42.86 75.00 83.33 
CSAmax > 15mm
2
 50.00 14.29 50.00 83.33 
Compression 50.00 42.86 50.00 66.67 
Proximal Enlargement 50.00 14.29 50.00 66.67 
Restricted Excursion 0.00 0.00 25.00 66.67 
Provocative Testing Excluded 14.29 75.00 66.67 
Classic Symptoms 50.00 100.0 100.0 66.67 
Nocturnal Symptoms 50.00 28.57 100.0 66.67 
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Sonographic Severity Categorization    
 A scoring matrix incorporating sonographic and clinical CTS indicators was used to 
categorize severity. (Table 3.1, 3.2)  Based on the scoring, US severity categorization resulted in 
1 normal, 7 mild, 6 moderate, and 5 severe CTS subjects. (Figure 4.3) Mean CSAmax increased 
with severity, increasing from 11.69mm² in normal subjects to 18.80 ± 2.01mm² in severe CTS 
subjects. Mean BMI, CSAa, and CSAb also increased with severity when normal values were 
excluded.  
Sonographic Severity versus NCS Severity 
 An overall agreement of 63.16% was observed between US and NCS severities, and the 
level of agreement was determined to be statistically significant using chi-square analysis  
Severity n= BMI CSAa CSAb CSAmax 
Normal 
 
 
   
NCS 2 21.55 ± 4.17 12.60 ± 7.90 9.92 ± 0.09 14.02 ± 5.89 
US 1 29.50 ± 0 11.36 ± 0 11.69 ± 0 11.69 ± 0 
Mild 
 
 
   
NCS 7 28.37 ± 2.92 11.45 ± 1.82 11.80 ± 2.74 12.49 ± 2.40 
US 7 27.04 ± 4.35 10.67 ± 2.41 11.38 ± 3.02 12.07 ± 2.82 
Moderate 
 
 
   
NCS 4 32.30 ± 8.29 12.48 ± 3.66 13.66 ± 4.09 14.93 ± 4.34 
US 6 28.18 ± 4.88 12.24 ± 3.21 13.67 ± 3.64 15.04 ± 3.51 
Severe 
 
 
   
NCS 6 39.62 ± 13.39 15.29 ± 4.55 14.94 ± 2.85 17.54 ± 3.42 
US 5 44.14 ± 12.20 17.49 ± 3.32 14.66 ± 2.83 18.80 ± 2.01 
Table 4.4 BMI and CSA Measurements by NCS and US Severity, CSA reported as mean ± SD in mm² 
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Table 4.5 Subject US and NCS Severity Category Percentage Agreement 
 
(p<0.05). The highest agreements were observed in mild (71.43%) and moderate CTS subjects 
(75.00%). Normal subject severity according to US did not agree with NCS severity, with US 
scoring categorizing one subject as mild and one as moderate. The majority of mild subject 
severity agreed (5/7) and both subjects not in agreement had an US severity of moderate. The 
majority of moderate subjects were also in agreement (3/4), with one scored as severe by US 
severity. Although severe CTS subject severity agreed between NCS and US in 66.67%, this 
category had the most disagreement between categorization. The two subjects not in agreement 
were scored as one normal and one mild by US severity. (Appendix X) Five of the seven subjects 
with differing NCS and US severities had missing values, including excursion, provocative 
testing, and symptom presentations. (Appendix X) Agreement increased between US and NCS 
severity when subjects with missing values were excluded, reaching an overall agreement of 
85.71%. (Table 4.5)  
  
 NCS Normal NCS Mild NCS Moderate NCS Severe Total 
All Subjects 
(n=19) 
0/2 (0.00%) 5/7 (71.43%) 3/4 (75.00%) 4/6 (66.67%) 12/19 (63.16%) 
Less subjects 
with excluded 
variables (n=14) 
Excluded 5/6 (83.33%) 3/4 (75.00%) 4/4 (100.0%) 12/14 (85.71%) 
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Chapter 5: Discussion 
 Historically, clinical evaluation and electrodiagnostic testing have been used to detect and 
stage the severity of CTS. Over the past two decades, the use of ultrasound to evaluate CTS has 
made many advances but has yet to surpass NCS, especially in the staging of CTS severity. The 
purpose of this study was to explore the use of multiple CTS indicators, blending both qualitative 
and quantitative variables, as a means for detecting and staging the severity of CTS.  
 A multitude of variables were evaluated to assess the difference between subjects and 
controls as well as the difference between NCS severity categories. Cross-sectional area was 
found to be useful in evaluating CTS, with significant differences observed between subjects and 
controls. This included the CSA at the proximal and mid carpal tunnel as well as the largest CSA 
measure (p<0.01). A moderately significant positive correlation was also found between these 
measures and NCS severity. Of the studies evaluated in Roll’s systematic review, the CSA at the 
level of the pisiform was the most commonly used and the most accurate measure.
25
 Similarly, 
the present study concluded the CSA at the level of the pisiform (CSAb) had the strongest 
correlation with CTS severity. Although this mid tunnel measurement may be the most 
indicative, other CSA measures may be necessary for a thorough evaluation. As explained by 
Roll,
25
 the carpal tunnel may not accommodate for swelling within the tunnel and swelling may 
occur just proximal to the tunnel instead. Ziswiler et al.
39
 identified the largest CSA within the 
carpal tunnel region, reporting high concordance between the largest CSA measurement and 
NCS. The present study also used the largest CSA measurement, although this was determined as 
the largest of the proximal and mid carpal tunnel CSA means. Employing the largest CSA 
measure aided in the proper assessment of subjects by US; three out of four subjects with 
pisiform-level CSA measurements less than 10mm
2
 and proximal tunnel CSA measurements 
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greater than 10mm
2
 were correctly staged by US with mild CTS.  Of the CSA parameters 
evaluated, CSA area difference was not found to be helpful in evaluating CTS. Unlike Akcar’s 
findings,
21 
a lack of significance was observed between subjects and controls and with increasing 
NCS severity in the current study. 
 Longitudinal appearance of the median nerve is seldom reported in the literature. As 
previously mentioned, the carpal tunnel may not accommodate an inflamed median nerve and a 
notched or hourglass appearance may be observed when the nerve is imaged longitudinally. 
Studies
 
have reported longitudinal compression sign (LCS) sensitivities ranging from 50-91.7% 
and specificities ranging from 62.5-100%, concluding that LCS is a useful sonographic variable 
for evaluating CTS.
34,35
 In concordance with these findings, over half of the subjects (52.63%) 
had observed compression which did not compare to the controls (0%). Similarly, proximal 
median nerve enlargement was observed in 42% of subjects and no controls. Kele also reported 
enlargement of the median nerve, describing a “bulbous nerve swelling” observed in 39 of the 55 
subjects with an identified compression sign.
34
 Distal enlargement was not found to be a 
beneficial parameter as it was only observed in two subjects. The highest percentages of 
compression and proximal enlargement were observed in subjects with severe CTS compared to 
other severity categories. 
 Evaluation of intraneural vascularity has received more attention over the last decade in 
the evaluation of CTS. Akcar evaluated the number of vessels observed in the median nerve 
within carpal tunnel region using power Doppler, reporting vessels in 50% of subjects and none 
of the controls. The authors proposed the quantification of vessels may be beneficial for CTS 
severity grading.
21
 Mallouhi concluded vascularity contributed more than gray-scale parameters 
in detecting CTS as compared to NCS, reporting the highest levels of sensitivity, PPV, NPV, and 
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overall accuracy rates were achieved with hypervascularity.
22
 Surprisingly, the current study 
observed intraneural flow in more asymptomatic controls than in symptomatic subjects (63% 
versus 53%, respectively). However, the results may be concordant with reported findings by 
Evans.
37
 The authors observed an inverse relationship between intraneural vascular flow and 
increasing severity, with peak systolic values of 3.75cm/s in symptomatic subjects and 4.26cm/s 
in asymptomatic controls. It was proposed that as progressive and chronic CTS develops, a 
decrease in tissue perfusion occurs, with a resultant decline in peak systole. Additional research 
conducted by Evans et al.
40 
evaluated intraneural flow within different regions of the carpal 
tunnel using spectral Doppler analysis in symptomatic subjects and asymptomatic controls. 
There were no statistical differences observed between subject and control waveform 
frequencies. Vascularity within the median nerve was also compared to the number of positive 
provocative tests. An increase in positive provocative tests corresponded to an increase in mid-
tunnel peak systolic velocities (PSV) and a decrease in proximal tunnel PSV, however the 
authors concluded there was not a clear directional relationship between provocative testing and 
PSV (R
2
=0.01). Although strict criteria were used for determining the presence of flow in the 
present study, this parameter may be better evaluated with a larger sample size to determine the 
clinical significance of intraneural flow.  
 Restricted excursion is another area that may benefit from future research utilizing larger 
sample sizes. Hough reported a reduced excursion in 57.9% of subjects and 8.1% of subjects, 
also reporting a higher prevalence in the dominant arm and in those with positive provocative 
testing.
28
 Although restricted excursion was only observed in 26.32% of subjects in the present 
study, it was only identified in moderate and of severe CTS subjects (25% and 66.67%, 
respectively). Also of interest, all subjects with restricted excursion had a CSAmax greater than 
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15mm
2
, compression and proximal enlargement signs, two or more positive provocative tests, 
and the presence of both classic and nocturnal symptoms.(Appendix X) Because this was a 
retrospective study, the previously established protocol for imaging controls did not include 
excursion evaluations. Comparative information between subjects and controls is not available; 
however the findings within the subject cohort are promising and may warrant additional 
exploration.        
 Although the use of qualitative parameters in addition to quantitative parameters is not a 
new approach, to the author’s knowledge the combination of variables used in this study is 
unique to current CTS research. Qualitative parameters used to evaluate CTS include 
longitudinal compression sign and echogenicity of the median nerve, typically in conjunction 
with quantitative parameters, CSA being the most common.
19,22,34,35
  In addition to qualitative 
assessments, Karadag et al.
41
 emphasized the importance of evaluating CTS from different 
perspectives. Karadag
41
 and Padua
20
 both explored the relationships between CSA and clinical 
presentations of CTS, including functional and symptom status questionnaires and provocative 
testing, in addition to NCS. Both authors reported significant findings between ultrasound and 
clinical presentations, as well as between ultrasound and NCS. The use of multidimensional 
assessments has also been shown to increase the predictive value of sonographic detection of 
CTS.
17,19,21,22,34-36 
Kele reported the best accuracy was received when using both qualitative and 
quantitative evaluations.
34
 Altinok reported increased accuracy in correctly classifying CTS 
severity when multiple variables were used.
36
 Similarly, Rempel evaluated the use of clinical 
parameters to predict the likelihood of CTS, reporting the greatest predictive value when 
combining the presence of classic/probable symptoms, nocturnal symptoms, and abnormal 
physical examination (positive provocative testing).
17 
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 Severity staging is especially important for the management of patients, including the 
decision to treat patients conservatively or proceed with surgical interventions. The usefulness of 
sonography to evaluate CTS will not surpass NCS until a reliable method has been established to 
accurately stage CTS severity. Few studies have been successful at categorizing CTS severity in 
agreement with NCS. El Miedany
24
 and Karadag
41
 both observed significant differences between 
severity groups (normal, mild, moderate, severe) using tiered CSA grading recommended by El 
Miedany, also reporting significant correlations between abnormal electrodiagnostic testing and 
ultrasound grades. Kang et al.
42
 revealed significant differences between controls and mild, 
moderate, and severe CTS subjects when using a wrist-to-forearm median nerve area ratio 
(WFR). When using the CSA at the wrist (CSA-W), a significant difference was observed 
between controls and subject severity groups but this parameter did not identify a significant 
difference between mild and moderate CTS subjects. While studies seem to easily differentiate 
between normal and abnormal subjects, research has often failed to determine significant 
differences between severity groups, especially in differentiating mild CTS from other 
severities.
42-45
  
 Based on the current research, a multifaceted approach was used in this study, employing 
both quantitative and qualitative parameters, evaluating the most prevalent sonographic measures 
in conjunction with clinical presentations. The scoring matrix employed for US severity scoring 
is a fusion of parameters inspired by research conducted by authors including El Miedany, Kele, 
Hough, and Rempel. Using tiered CSA levels, qualitative longitudinal appearance and excursion 
evaluations, and clinical presentations, a semi-quantitative scale has been introduced with the 
particular goal of aiding severity staging. Although this pilot study has a small sample of 
symptomatic subjects (n=19) evaluated by NCS and sonography, significant agreement was 
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observed between NCS and US severity (p<0.05). Ultrasound severity scoring correctly 
classified 71% of mild, 75% of moderate, and 67% of severe CTS subjects according to NCS 
severity.    
 Although the current scoring matrix correctly identified 84% of the controls as normal 
(16% graded as mild), the symptomatic subjects diagnosed as normal by NCS had the most 
disagreement between NCS and US. Of the two normal subjects, one was graded as mild and one 
was graded as moderate. The first subject, graded as mild, did not have any positive ultrasound 
indicators or positive provocative testing, but was scored as mild based on the presence of classic 
and nocturnal symptoms. The normal subject graded as moderate was even more perplexing, 
with a CSAmax of 18mm
2
, compression, and proximal enlargement.(Appendix XI)  
 It has been proposed by other authors that false-positive ultrasound findings may in fact 
be attributed to false-negative NCS findings.
19,46 
Similarly, authors have concluded that subjects 
with typical CTS clinical presentations and normal evaluations, either by NCS or US, should not 
be precluded from a diagnosis of CTS and follow-up testing may be necessary.
19,24,37,43,44,46
  
Mondelli
43
 reported 23.5% of subjects clinically diagnosed with mild CTS had negative NCS and 
US tests. Similarly, Moran
44
 reported 28.6% of subjects with suspicion of CTS had negative 
NCS results. In a study evaluating clinically diagnosed CTS subjects with normal NCS, 
Rahmani
19
 calculated a probability of CTS ranging from approximately 35-90% depending on 
the number of positive ultrasound parameters. Wong
46
 reported a false-positive US rate of 11-
15%, a rate comparable to generally accepted NCS false-negative rates. The authors suggested 
these subjects may be better classified as false-negative NCS result rather than a false-positive 
upon US.  
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 Several authors have offered possible explanations for the discordance between CTS 
symptoms and US or NCS evaluations.
37,43,44,46
  In the early stages of CTS, intermittent ischemia 
caused by repetitive strain can present as paresthesia in affected individuals, occurring prior to 
demyelination of the nerve. As ischemia ensues, damaged nerve-blood barriers allow capillary 
leakage into the epineurium, leading to edema. Increased cross-sectional area of the median 
nerve will not occur until after edema triggers the inflammation process, also triggering 
hypervascularity within the area. If NCS is performed prior to demyelination, the findings will 
likely be normal. Similarly, if US is performed before edema has effectively initiated the 
inflammation process, ultrasound parameters will also likely be normal. It is also possible that 
acute inflammation can increase CSA and vascularity prior to demyelination, potentially creating 
an abnormal US examination and a normal NCS examination. Considering the mechanisms of 
acute inflammation, the subject staged as normal by NCS with a CSA greater than 18mm
2
 may 
represent an NCS false-negative, rather than an US false-positive.  
 The use of sonography as a first-line diagnostic test has been proposed within the 
literature.
15,18,24,39,44,46,47
 Generally accepted advantages of sonography include wide availability, 
noninvasive, well-tolerated by patients, and cost-effective. In a random post-examination survey 
conducted by Visser et al.,
47 
60% of patients preferred sonography compared to only 5% 
reporting a slight preference for EMG. Of the proponents for first-line sonography evaluations, 
most concur that electrodiagnostic testing and ultrasound would be complementary, as 
electrodiagnostic testing would be beneficial for the evaluation of symptomatic subjects with 
normal US findings.
18,39,43,44,47 
Research has shown increasing the use of sonography for CTS 
evaluation can provide significant reductions in cost and time.
15,39,46 
In Hong Kong, a 30 minute 
electrodiagnostic evaluation costs $320 (U.S. dollars), compared to a $60 (U.S. dollar) 15 minute 
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sonographic examination.
46
 Ziswiler
39
 concluded the use of sonography for the initial evaluation 
of patients with CTS symptoms could cut the use of EDX in half, resulting in a cost reduction of 
$108 (U.S. dollars) per symptomatic wrist. 
 
While the benefits of sonography are encouraging, 
the progress to sonography as a first-line examination for CTS would benefit from a universally 
accepted protocol and method for staging the severity of CTS. 
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Chapter 6: Conclusion 
 Although the results are promising and may be of value in future research, there are 
several inherent limitations. The most notable of the limitations is the small sample size. Based 
on a combined subject and control sample size of 38, as well as a smaller cohort of 19 
symptomatic subjects undergoing both NCS and US testing, the results obtained in this pilot 
study cannot be generalized to larger populations. Additionally, because this was a convenience 
sample, recruiting volunteer subjects appearing for NCS evaluation and volunteer controls 
responding to flyers, the generalizability of the results is further reduced. Prospective studies 
with increased recruitment are necessary to determine the clinical significance of the 
multidimensional evaluation and scoring system proposed in this pilot study. 
  Missing parameter values was another significant limitation in this pilot study, 
potentially causing an under-estimation of parameter frequency and US severity-scoring. Five 
symptomatic wrists were missing data, specifically excursion (1), provocative testing (4), and 
presence of classic and nocturnal symptoms (3). Pertaining to the missing symptom information, 
although the nerve conduction testing was order for symptoms consistent with CTS, a completed 
functional and symptom status questionnaire was not completed and these subjects also had 
missing provocative testing. The individuals were mentally handicapped, with a general lack of 
understanding and inability to provide information pertaining to their symptoms. Although the 
missing data was a disadvantage, it should be noted that this is certainly a situation that may be 
encountered in larger studies. Specific populations and settings may be unable to provide 
information relevant to their care, including cognitively challenged or geriatric populations.      
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 Another limitation of this pilot study is the lack of comparison between subject and 
control electrodiagnostic testing. Controls did not undergo NCS evaluation due to a lack of 
funding for such a venture. This would have been especially useful for asymptomatic controls 
presenting with abnormal US findings presentations. As previously stated, this was a 
convenience sample relying on volunteer controls from an academic setting. Three asymptomatic 
controls had a CSA larger than 13mm
2
, one of which had a CSA larger than 15mm
2
. These 
subjects were all staged as mild CTS by US. Comparing the US staging, based on the enlarged 
CSA values, to NCS findings may have provided valuable information. In addition to increased 
sample sizes, future research would benefit from the inclusion of electrodiagnostic testing on 
both symptomatic subjects and asymptomatic controls to further evaluate the accuracy of the US 
scoring matrix.  
 Continued focus on excursion in future research is also suggested. This pilot study was a 
retrospective case-control study, and control data was attained from an established database of 
examinations. The original protocol did not include the evaluation of excursion, resulting in a 
lack of information on excursion in healthy, asymptomatic controls. Although restricted 
excursion was only observed in subjects with NCS findings diagnosing moderate or severe CTS, 
there is a need for comparative studies between subjects and controls. Future studies replicating 
the combination of parameters and scoring system should include the evaluation of median nerve 
excursion in all individuals.  
 The qualitative evaluation of excursion did provide results worthy of future exploration; 
however this parameter was intended to be a quantitative variable, reporting excursion rates in 
millimeters. Originally, frame-by-frame analysis was proposed to evaluate distal movement of 
the median nerve upon active wrist extension. Audio video interleave (AVI) files were uploaded 
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into a video processing software program, VirtualDub (version 1.9.11), used to break down the 
files into individual frames. Using Microsoft Paint, the individual frames were marked with 
colored dots at the carpal tunnel inlet on every fifth frame to create a point of reference. 
Longitudinal segments were then color highlighted on every other frame. The individual frames 
were then reassembled and evaluated. It was hypothesized that the observed pixel shifts would 
allow for the angle of excursion.and forward motion to be evaluated, converting the movement 
into millimeters for a quantifiable measurement. After repeated attempts, this method of analysis 
was unsuccessful, and the current qualitative assessment of excursion was adopted. Although 
quantitative evaluations of excursion were not successful in this pilot study, future research 
should explore existing or new techniques to accurately measure excursion rates. Confirmatory 
studies may indicate restricted excursion is a useful parameter to evaluate and stage the severity 
of CTS.  
 In conclusion, significant agreement between US and NCS severities was achieved using 
a multidimensional evaluation of sonographic and clinical parameters. Additional research using 
the qualitative and quantitative evaluations employed in the present study may be valuable for 
guiding clinical practice, and larger replicated studies are encouraged. The practicality of the 
proposed system should be evaluated as this approach may provide clinicians with a holistic 
approach for the initial diagnosis and severity staging of CTS.  
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List of Abbreviations 
AANEM American Association of Neuromuscular and Electrodiagnostic Medicine 
ARM Right (R) or left (L) wrist 
AVI Audio video interleave 
BMI Body mass index 
CLASS SYMP Classic symptoms 
COMP Compression  
CON Control  
CON ID Control identification number 
CSA Cross-sectional area 
CSAa Cross-sectional area at the carpal tunnel inlet, at the level of the radial-ulnar joint 
CSAb Cross-sectional area at mid-tunnel, at the level of the pisiform 
CSAmax Largest of the inlet and mid-tunnel cross-sectional area measurement 
CSA AREA DIFF Cross-sectional area difference (CSAb-CSAa) 
CT Computed tomography 
CTS Carpal tunnel syndrome 
DIST ENLG Distal enlargement 
EDX Electrodiagnostic study 
EMG Electromyography 
EXCURS Excursion  
FSS Functional status survey 
IN FLOW Intraneural vascular flow 
LCS Longitudinal compression sign 
MATCH Matched subject or control identification number 
MRI Magnetic resonance imaging 
MSK Musculoskeletal  
NCS Nerve conduction study 
NCS CAT Nerve conduction study severity category 
NOCT SYMP Nocturnal symptoms 
NPV Negative predictive value 
NR No response 
PPV Positive predictive value 
PROV TEST Provocative testing  
PRX ENLG Proximal enlargement  
ROI Region of interest 
ROM Range of motion 
SCORE Number of positive parameters 
SD Standard deviations 
SSS Symptom severity survey 
SUB Subject 
SUB ID Subject identification number  
US Ultrasound 
US CAT Ultrasound severity category 
VTI Velocity time integrals 
WFR Wrist-to-forearm median nerve area ratio 
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DATA WORKSHEET 
Subject:   Hand:   R   L Exclusion:   
DOB:   
  
Symptomatic: Y N 
Exam date:   Gender: M  F Dominant Hand: R L 
BMI:   
      
        
 
Cross-Sectional Analysis (mm²) 
     
  
CSAa 
 
CSAb 
   
 
1   1   
   
 
2   2   
   
 
3   3   
   
 
4   4   
   
 
5   5   
   
        
 
Trimmed Average   
 
  
   
        
 
Frame Number   
 
  
   
        
 
Longitudinal Appearance 
     
 
Compression Present Absent Excluded 
   
 
Enlargement: 
      
 
Distal Present Absent Excluded 
   
 
Proximal Present Absent Excluded 
   
        
 
Intraneural Flow Present Excluded 
    
 
Waveforms: Total   
    
  
Present   Excluded   
  
        
 
Excursion Normal Restricted Excluded 
   
  
ROM:   
    
        
 
Provocative Testing 
     
 
Phalen's + - 
    
 
Tinel's + - 
    
 
Durkin's + - 
    
        
 
NCS Diagnosis Normal Mild Moderate Severe 
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SCORING MATRIX 
     ID:   
   
     
 
Sonographic Evaluation 
  
     
 
CSA: 
  
 
Largest CSA >10mm2 1 
 
 
Largest CSA >13mm² 1 
 
 
Largest CSA >15mm² 1 
 
     
 
Longitudinal Appearance: 
  
 
Compression 1 
 
 
Proximal Swelling 1 
 
 
Restricted Excursion 1 
 
     
 
Total Positive US Indicators: 
 
  
     
 
Clinical Examination and Symptoms 
 
     
 
Positive provocative test 1 
 
 
Classic symptoms present 1 
 
 
Nocturnal symptoms present 1 
 
     
 
Total Positive Clinical Indicators:   
     
 
Total Positive Indicators: 
 
  
     
 
CTS Severity 
   
 
Normal 0-1   
 
 
Mild 2-4   
 
 
Moderate 5-7   
 
 
Severe 8-9   
 
     
 
NCS Category:   
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Sonographic Images: Cross-Sectional Area of the Median Nerve 
    
 
 
 
  
Subject Control 
Cross-sectional area of the median nerve at the level of the pisiform (CSAb), calculated using a direct trace method. CSA greater than 
10mm
2
 considered abnormal.  
MN-median nerve, Sca-scaphoid, Pis-pisiform 
Pis 
MN 
Sca 
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Sonographic Images: Longitudinal Appearance of the Median Nerve 
    
 
 
 
 
  
Subject Control 
Longitudinal images used to subjectively evaluate enlargement and compression of the median nerve in the carpal tunnel region. 
MN-median nerve, FT-flexor tendons, Rad-radius, Lun-lunate, Cap-capitate 
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Sonographic Images: Excursion of the Median Nerve 
 
  
43.121 64.121 115.121 
L 
C 
R 
MN 
Individual frames (frame number located below image) from cine clip of median nerve excursion upon active wrist extension. Intraneural 
reference point and anatomical landmarks used to subjectively classify excursion as normal or restricted.  
MN-median nerve, R-radius, L-lunate, C-capitate 
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